Hypertension control during the COVID-19 pandemic: results of the MMM2021 in Russia
Repetitive quarantines and social restrictions during the coronavirus disease 2019 (COVID-19) pandemic have negatively affected the population health in general, and the control of hypertension (HTN) in particular.Aim. To evaluate the control of HTN in the Russian population during the COVID-19 peri...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2022-05-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/5014 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849689701737299968 |
|---|---|
| author | O. P. Rotar A. M. Erina M. A. Boiarinova E. V. Moguchaia E. P. Kolesova K. M. Tolkunova A. R. Gorshevaya K. A. Kovalenko E. A. Smirnova Ya. A. Belenikina I. V. Bikushova M. A. Kercheva A. V. Svarovskaya M. M. Petrova D. S. Kaskaeva P. A. Shcherbina S. Yu. Nikulina A. A. Chernova A. V. Levshin A. O. Shabelsky E. I. Zheleznyak E. A. Kartashova Yu. A. Sharapova T. M. Chernykh M. V. Derevyanchenko V. V. Fedotov N. Yu. Shaposhnikova E. R. Makeeva O. V. Ulitina M. V. Menzorov E. M. Dolya A. A. Tanicheva A. O. Konradi E. V. Shlyakhto |
| author_facet | O. P. Rotar A. M. Erina M. A. Boiarinova E. V. Moguchaia E. P. Kolesova K. M. Tolkunova A. R. Gorshevaya K. A. Kovalenko E. A. Smirnova Ya. A. Belenikina I. V. Bikushova M. A. Kercheva A. V. Svarovskaya M. M. Petrova D. S. Kaskaeva P. A. Shcherbina S. Yu. Nikulina A. A. Chernova A. V. Levshin A. O. Shabelsky E. I. Zheleznyak E. A. Kartashova Yu. A. Sharapova T. M. Chernykh M. V. Derevyanchenko V. V. Fedotov N. Yu. Shaposhnikova E. R. Makeeva O. V. Ulitina M. V. Menzorov E. M. Dolya A. A. Tanicheva A. O. Konradi E. V. Shlyakhto |
| author_sort | O. P. Rotar |
| collection | DOAJ |
| description | Repetitive quarantines and social restrictions during the coronavirus disease 2019 (COVID-19) pandemic have negatively affected the population health in general, and the control of hypertension (HTN) in particular.Aim. To evaluate the control of HTN in the Russian population during the COVID-19 period based on the results of screening for HTN May Measurement Month 2021 (MMM2021).Material and methods. During May-August 2021, 2491 participants from 11 Russian regions took part in the screening. Participation was voluntary without restrictions on sex. All participants were over 18 years of age. During the screening, blood pressure (BP) was measured three times using automatic and mechanical BP monitors. In addition, a questionnaire was filled out on behavioral risk factors, comorbidities and therapy. HTN was diagnosed with systolic BP ≥140 mmHg and/ or diastolic blood pressure ≥90 mmHg and/or taking antihypertensive therapy. The questionnaire included questions about prior COVID-19, vaccinations and their impact on the intake of antihypertensive drugs.Results. The analysis included data from 2461 respondents aged 18 to 92, of which 963 were men (39,1%). The proportion of hypertensive patients was 41,0%, while among them 59,0% took antihypertensives and 30,9% were effectively treated. In comparison with pre-pandemic period according to MMM2018-2019, the higher proportion of HTN patients in the Russian sample was revealed during MMM2021 (41,0% vs 31,3%, p<0,001) with a comparable proportion of patients receiving antihypertensive therapy (60,7% vs 59,0%, p=0,05) and treatment efficacy (28,7% vs 30,9%, p=0,36). Monotherapy was received in 44,7% of cases, while dual and triple combination therapy — in 30,9% and 14,1%, respectively. The majority of respondents (~90%) did not adjust their antihypertensive therapy during the COVID-19 pandemic.Conclusion. According to HTN screening in Russia, there is persistent ineffective control of HTN, which may be due to both the worsening pattern of behavioral risk factors, limited access to healthcare during COVID-19, and the inertia of physicians and low adherence of patients due to the asymptomatic HTN course in the majority. |
| format | Article |
| id | doaj-art-ee87f4bcda68479c815b4ad858bda256 |
| institution | DOAJ |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| publishDate | 2022-05-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj-art-ee87f4bcda68479c815b4ad858bda2562025-08-20T03:21:31Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202022-05-0127410.15829/1560-4071-2022-50143530Hypertension control during the COVID-19 pandemic: results of the MMM2021 in RussiaO. P. Rotar0A. M. Erina1M. A. Boiarinova2E. V. Moguchaia3E. P. Kolesova4K. M. Tolkunova5A. R. Gorshevaya6K. A. Kovalenko7E. A. Smirnova8Ya. A. Belenikina9I. V. Bikushova10M. A. Kercheva11A. V. Svarovskaya12M. M. Petrova13D. S. Kaskaeva14P. A. Shcherbina15S. Yu. Nikulina16A. A. Chernova17A. V. Levshin18A. O. Shabelsky19E. I. Zheleznyak20E. A. Kartashova21Yu. A. Sharapova22T. M. Chernykh23M. V. Derevyanchenko24V. V. Fedotov25N. Yu. Shaposhnikova26E. R. Makeeva27O. V. Ulitina28M. V. Menzorov29E. M. Dolya30A. A. Tanicheva31A. O. Konradi32E. V. Shlyakhto33Almazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterSt. Petersburg State Pediatric Medical UniversityI.P. Pavlov Ryazan State Medical UniversityI.P. Pavlov Ryazan State Medical UniversityI.P. Pavlov Ryazan State Medical UniversityTomsk National Research Medical CenterTomsk National Research Medical CenterV.F. Voyno-Yasenetsky Krasnoyarsk State Medical UniversityV.F. Voyno-Yasenetsky Krasnoyarsk State Medical UniversityV.F. Voyno-Yasenetsky Krasnoyarsk State Medical UniversityV.F. Voyno-Yasenetsky Krasnoyarsk State Medical UniversityV.F. Voyno-Yasenetsky Krasnoyarsk State Medical University; Federal Research and Clinical CenterAsinovskaya District HospitalAsinovskaya District HospitalRostov State MedicalRostov State MedicalN.N. Burdenko Voronezh State Medical UniversityN.N. Burdenko Voronezh State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityFirst-Called Apostle Andrew City Clinical HospitalFirst-Called Apostle Andrew City Clinical HospitalUlyanovsk State UniversityV.I. Vernadsky Crimean Federal University, S.I. Georgievsky Medical AcademyAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterRepetitive quarantines and social restrictions during the coronavirus disease 2019 (COVID-19) pandemic have negatively affected the population health in general, and the control of hypertension (HTN) in particular.Aim. To evaluate the control of HTN in the Russian population during the COVID-19 period based on the results of screening for HTN May Measurement Month 2021 (MMM2021).Material and methods. During May-August 2021, 2491 participants from 11 Russian regions took part in the screening. Participation was voluntary without restrictions on sex. All participants were over 18 years of age. During the screening, blood pressure (BP) was measured three times using automatic and mechanical BP monitors. In addition, a questionnaire was filled out on behavioral risk factors, comorbidities and therapy. HTN was diagnosed with systolic BP ≥140 mmHg and/ or diastolic blood pressure ≥90 mmHg and/or taking antihypertensive therapy. The questionnaire included questions about prior COVID-19, vaccinations and their impact on the intake of antihypertensive drugs.Results. The analysis included data from 2461 respondents aged 18 to 92, of which 963 were men (39,1%). The proportion of hypertensive patients was 41,0%, while among them 59,0% took antihypertensives and 30,9% were effectively treated. In comparison with pre-pandemic period according to MMM2018-2019, the higher proportion of HTN patients in the Russian sample was revealed during MMM2021 (41,0% vs 31,3%, p<0,001) with a comparable proportion of patients receiving antihypertensive therapy (60,7% vs 59,0%, p=0,05) and treatment efficacy (28,7% vs 30,9%, p=0,36). Monotherapy was received in 44,7% of cases, while dual and triple combination therapy — in 30,9% and 14,1%, respectively. The majority of respondents (~90%) did not adjust their antihypertensive therapy during the COVID-19 pandemic.Conclusion. According to HTN screening in Russia, there is persistent ineffective control of HTN, which may be due to both the worsening pattern of behavioral risk factors, limited access to healthcare during COVID-19, and the inertia of physicians and low adherence of patients due to the asymptomatic HTN course in the majority.https://russjcardiol.elpub.ru/jour/article/view/5014screeninghypertensionblood pressureadherencecovid-19 |
| spellingShingle | O. P. Rotar A. M. Erina M. A. Boiarinova E. V. Moguchaia E. P. Kolesova K. M. Tolkunova A. R. Gorshevaya K. A. Kovalenko E. A. Smirnova Ya. A. Belenikina I. V. Bikushova M. A. Kercheva A. V. Svarovskaya M. M. Petrova D. S. Kaskaeva P. A. Shcherbina S. Yu. Nikulina A. A. Chernova A. V. Levshin A. O. Shabelsky E. I. Zheleznyak E. A. Kartashova Yu. A. Sharapova T. M. Chernykh M. V. Derevyanchenko V. V. Fedotov N. Yu. Shaposhnikova E. R. Makeeva O. V. Ulitina M. V. Menzorov E. M. Dolya A. A. Tanicheva A. O. Konradi E. V. Shlyakhto Hypertension control during the COVID-19 pandemic: results of the MMM2021 in Russia Российский кардиологический журнал screening hypertension blood pressure adherence covid-19 |
| title | Hypertension control during the COVID-19 pandemic: results of the MMM2021 in Russia |
| title_full | Hypertension control during the COVID-19 pandemic: results of the MMM2021 in Russia |
| title_fullStr | Hypertension control during the COVID-19 pandemic: results of the MMM2021 in Russia |
| title_full_unstemmed | Hypertension control during the COVID-19 pandemic: results of the MMM2021 in Russia |
| title_short | Hypertension control during the COVID-19 pandemic: results of the MMM2021 in Russia |
| title_sort | hypertension control during the covid 19 pandemic results of the mmm2021 in russia |
| topic | screening hypertension blood pressure adherence covid-19 |
| url | https://russjcardiol.elpub.ru/jour/article/view/5014 |
| work_keys_str_mv | AT oprotar hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT amerina hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT maboiarinova hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT evmoguchaia hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT epkolesova hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT kmtolkunova hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT argorshevaya hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT kakovalenko hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT easmirnova hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT yaabelenikina hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT ivbikushova hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT makercheva hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT avsvarovskaya hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT mmpetrova hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT dskaskaeva hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT pashcherbina hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT syunikulina hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT aachernova hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT avlevshin hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT aoshabelsky hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT eizheleznyak hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT eakartashova hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT yuasharapova hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT tmchernykh hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT mvderevyanchenko hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT vvfedotov hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT nyushaposhnikova hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT ermakeeva hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT ovulitina hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT mvmenzorov hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT emdolya hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT aatanicheva hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT aokonradi hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia AT evshlyakhto hypertensioncontrolduringthecovid19pandemicresultsofthemmm2021inrussia |